Mantra acquires Cutimed and the Cutibase brand

BROSSARD, April 2, 2026 — Mantra Pharma is proud to announce the acquisition of the Quebec-based company Cutimed, manufacturer of the Cutibase dermatological skincare line, well known among dermatologists and pharmacists and widely distributed in pharmacies across Quebec.

Effective December 15, 2025, Mantra Pharma Inc. will no longer be responsible for promoting Ulticare® products on behalf of Stericycle Inc.

BROSSARD, March 17, 2025 – Myriad Pharma, the division of Mantra Pharma specializing in the marketing of over-the-counter products, is expanding its representation network with two new partners: Laboratoire Modilac and La ligne J'ARRÊTE.

BROSSARD, January 20, 2025 – Mantra Pharma, a leading Quebec-based developer and marketer of generic medications, announces the upcoming launch of M-METFORMIN, an addition to its generic range.

We are delighted to share that Mantra Pharma proudly took part in the 2024 Noeudvembre campaign, organized by PROCURE. Held throughout November, this annual effort is dedicated to raising public awareness and funding critical research in the fight against prostate cancer, the most common cancer among men.

BROSSARD, QC, February 8, 2024 – At the height of the season when respiratory viruses are on the rise in the population, Mantra is solidifying its supply of an oral antibiotic whose shortage last year caused major issues for medical staff and parents of sick children.

Brossard, January 5, 2024—People suffering from dyslipidemia, a frequently trivialized and even neglected silent disease, often underestimate its impact. Although drug therapy alternatives are available on the market, Mantra Pharma is pleased to inform people with dyslipidemia that a new natural solution is now available to help them optimize their lipid profile and improve their cardiovascular health. The product, named Cardiosmile, is now available behind the counter in Quebec pharmacies.

Brossard, November 7, 2023 – Mantra Pharma, a company that develops and markets generic drugs and over-the-counter products, has taken another step to achieve its growth objectives by signing an agreement to bring in Marcan Pharmaceuticals, a Canadian pharmaceutical company, as a shareholder.

BROSSARD, May 16, 2023— Mantra Pharma maintains impressive growth completing 39 product launches, including all strengths, in the past 16 months. A remarkable performance for a Quebec company competing in a market once dominated by major international pharmaceutical corporations.